Earnings season is in full swing and investors will be watching their investments closely.
Traders may also be looking for trading opportunities either before or after specific company reports are released. Volatility certainly tends to increase around earnings reports and savvy traders will look to profit from it.
Either way, a lot of attention is given to the “big boys,” and this week brings several big biotech names.
The first big biotech name to watch this week is Amgen, Inc. (NASDAQ: AMGN).
Amgen releases its report on Tuesday after the bell, and the consensus estimate is for $2.05 per share.
The next big name on the list is Biogen Idec Inc (NASDAQ: BIIB), which is set to release its report on Wednesday before the market opens.
Biogen’s consensus comes in at $3.74 per share, and the whisper on the Street is that Biogen will beat estimates.
Right after Biogen delivers its report, then comes Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX).
Vertex releases earnings after the bell on Wednesday and is expected to come in at ($0.61) per share.
Thursday brings two big biotech names, both of which are releasing their earnings before the bell.
One of those names is Celgene Corporation (NASDAQ: CELG).
The expectations for Celgene are for $1.00 per share.
The other biotech releasing on Thursday is Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN).
Investors are looking for $1.29 per share from Alexion’s release.
See more from Benzinga
- The 5 Biggest Biotech Stocks
- Celgene Sells Off, But Begins Move Back Up
- Are There Any Winners Left In The Biotech Space?
© 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.